Catalyst Wire Dossier Catalyst Wire Dossier

AZD3839

AZD3839 · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD3839, covering 2012-04-06 to 2012-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers [Phase 1]

See pricing